Measures to Generate Clean Energy Bolster Use of Building Integrated Photovoltaics

The use of building integrated photovoltaic (BIPV) technology is less detrimental to the environment and is also benefitting in terms of lower cost of power generation than conventional means of power generation. Moreover, in construction undertakings, the integration of BIPV with the building structure reduces overall construction cost substantially.

Q. What are the major factors influencing the use of BIPV for energy generation?

A. Across the world, increasing awareness about the reduction of carbon footprint is leading to the tapping of renewable energy sources. This is mainly due to the depleting fossil fuel reserves and global warming which are increasing the temperature of the Earth.

In many parts of the world, the use of renewable sources such as solar panels for energy generation receives incentives from the government. Low cost of electricity generation combined with Feed in Tariff (FIT) rates are the other factors driving electricity generation using BIPV technology.

Q. Does the use of BIPV have cost implications on building construction?

A. No. The cost incurred in BIPV is neutralized by reducing the amount spent on labor and building materials that would be utilized to construct that part of the building. As the building comes into operation, the use of sunlight for generating electrical energy leads to additional savings. Due to this, BIPV is one of the fastest growing components of the photovoltaic industry.


Q. What lies ahead for the growth of the BIPV market in Asia Pacific?

A. In Asia Pacific, new norms and regulations about the use of renewable energy and government subsidies for the use of solar power for energy generation are driving the utilization of BIPV technology. For instance, in China, mandates such as the Renewable Energy Law 2006 are driving the use of renewable energy in the commercial sector. The increasing Asian population and government initiatives are offering new opportunities for BIPV in the residential sector.

Q. How are energy efficiency norms for buildings mandating the integration of photovoltaic?

A. Stringent rules for energy efficiency of buildings is making it a no-brainer to integrate photovoltaic at the time of construction.

The recently concluded Intersolar Europe trade exhibition had discussions on the ways the BIPV market in Europe can be stimulated. This included discussion of policies that would implement energy efficiency goals across Europe, and install BIPV in new building constructions and photovoltaic panels on existing rooftops.

The use of BIPV, however, changes the overall building cost but it is directly linked to the energy efficiency goals of the building. The conclusion of the meet was if energy efficiency targets are hard and firm, then it becomes almost a no-brainer to integrate solar at the time of building construction along with a host of energy-saving measures.

High Incidences of Hearing Losses Induces High Demand for Hearing Aids

Hearing aids are devices that provide assistance to the partially deaf people by amplifying the sound signals. The hearing aids market is anticipated to boom owing to the increasing number of hearing impairment cases. However, a report by WHO indicates that the hearing aid production globally could hardly meet 10% of the total need in 2015.

Growing Geriatric Population Fuels the Demand for Hearing Aids: With a rising global population crossing the age of 60, the risk of hearing impairment is also increasing. The sales of hearing aids are positively influenced by the increasing geriatric population across the globe. Moreover, features such as proper insulation and easy-fit on the ear make hearing aid a popular choice amongst the old-age population.
Government initiatives Back the Growth of Hearing Aids Market: An increase in the level of awareness in the patients regarding the hearing aids in the last few years can be attributed to government campaigns and incentives aimed at curbing the incidence of hearing loss. The technological advancements are also playing a significant role in augmenting the sales of hearing aids. The introduction of rechargeable hearing aids with quick charging features and long lasting battery life will bolster the growth of the market. 
High Prevalence of Hearing Impairment among Adults Open Avenues for Research: Various studies report that nearly 6% of the global population suffers from hearing loss, out of which approximately 95% are adults. The incidences of hearing impairment are increasing at an alarming rate. This opens avenues for development of new products.
Research Report: http://www.transparencymarketresearch.com/hearing-aid-market.html

Opportunities for the growth of the market are most conducive in Europe and has registered the highest number of users of hearing aids. However, rising investment in the healthcare infrastructure and high unmet medical needs are likely to make Asia Pacific market lucrative.

Advent of Cognitive Learning to Revolutionize Development of E-Clinical Solution Software

E-clinical solution software comprises programs intended to make the process of data management in the global healthcare sector easier than can be done with conventional methods. The healthcare industry generates a massive volume of patient data every day, which requires careful storage in a way that also allows easy access for future use. The confidentiality of patient data also makes the storage system used for healthcare data crucial. This has driven the demand for digital data storage systems in the last few years and several major players have adopted various types of web-based e-clinical solution software to boost their productivity. 

According to Transparency Market Research, the global market for e-clinical solution software was valued at US$3 bn in 2014. Exhibiting a robust growth rate of 13.80% from 2014 to 2020, the market is expected to rise to a valuation of US$6.8 bn. 

How is cognitive learning impacting the global e-clinical solution software market?

One of the major points discussed at last month’s Digital Health Summer Summit in San Francisco was the potential applications of cognitive learning programs in the healthcare industry. While smart data logging and tracking software is becoming common in healthcare applications, the advent of cognitive learning in the field represents a crucial milestone for the industry.

Cognitive learning programs have the ability to not only organize and secure data, but also to come up with insights based on the data and to modify the conclusions when more data is added. This presents a major advancement for the healthcare industry owing to the increased accuracy and reliability cognitive learning solutions provide. 

Which is the most popular delivery mode for e-clinical solution software?

By delivery mode, the demand for web-based e-clinical solution software dominates the global market. However, cloud-based delivery of e-clinical solution software is expected to become increasingly popular in the coming years. While web-based data storage revolutionized the healthcare industry by demonstrating the benefits of digitization, cloud-based data storage represents the logical next step of outsourcing data storage services. Cloud-based delivery of e-clinical solution software allows the end users to focus their resources on improving their core operations, which has driven the demand for cloud services. 

Of the major end users of e-clinical solution software, the pharmaceutical industry took up the leading share in the global market in 2014. The consistent need for precise data in the pharmaceutical industry has made the sector a prominent end user of e-clinical solution software, with the increasing number of clinical trials expected to provide a major boost to the demand for e-clinical solution software in the coming years. However, clinical research organizations (CROs) are another major end user segment of the global e-clinical solution software market and are likely to exhibit the fastest growth in demand in the 2014-2020 forecast period.

Browse Research Release: 

What does the increasing number of clinical trials in Asia Pacific signify for the e-clinical solution software market?

Currently, North America is the global leader in the e-clinical solution software market and holds a share of close to 60% due to the strong presence of the pharmaceutical industry in the region. Nevertheless, the increasing population in Asia Pacific is expected to result in an increase in the demand for e-clinical solution software, with North America’s share expected to drop to about 55% by 2020. Several pharmaceutical and life sciences companies are setting a firm foothold in rampant Asia Pacific economies, where the demand for pharmaceutical products is likely to grow significantly in the coming years.

Increasing Research into Longer Lasting Peptide Therapeutics Set to Bear Fruit

Peptides are short-chain amino acids used therapeutically in the treatment and management of several diseases, including major killers such as diabetes. Peptides are differentiated from proteins by the length of their amino acids; proteins have longer amino acid chains than peptides. Peptides such as insulin have been in therapeutic use for a long time and have helped drive investment in research into the therapeutic efficacy of peptides. Due to the growing investment in the sector, peptide therapeutics are becoming increasingly important in the global healthcare sector. 

Browse Full Market Research Report: 

According to Transparency Market Research, the global peptide therapeutics market is expected to exhibit a low yet steady 2.8% CAGR between 2014 and 2020. The market’s valuation is expected to rise from US$18.9 bn in 2013 to a projected US$23.7 bn by the end of the forecast period. Apart from the established therapeutic uses of peptides, their potential use in the treatment of various cancers, neurological disorders, hematological disorders, and cardiovascular and respiratory disorders is expected to be crucial for the market’s growth in the forecast period. 

How important will the growing prevalence of diabetes be for the peptide therapeutics market?

Despite the increasing research into the use of peptides in the treatment of various other diseases, the use of insulin in diabetes management remains the key application of peptide therapeutics. Diabetes has not shown any signs of slowing down since insulin became the first therapeutically used peptide; in fact, its prevalence has grown rapidly in the last few decades, as the increasing prosperity in developed economies has made various risk factors for diabetes increasingly accessible to the average consumer. The disease is expected to remain a global healthcare concern in the coming years, driving the market for advanced insulin products.

Apart from the use of insulin in diabetes management, what is the key driver for the peptide therapeutics market?

The increasing innovation of advanced peptide therapeutics is another key driver for the global peptide therapeutics. As the infrastructure for clinical research into peptide therapeutics becomes more refined, the use of high-precision methods and tools has allowed market giants to come up with safe and effective peptide therapeutics. Due to the increasing consumer satisfaction brought about by technological progress, collaboration between biotech and pharmaceutical companies is expected to be a prominent feature of the global peptide therapeutics market in the coming years.

A key advancement in the field of peptide therapeutics is the innovation of stable peptide molecules that aren’t degenerated by the body as quickly as conventional peptides. The conventional mode of delivering peptide therapeutics has involved permeability enhancement, which comprises various techniques to ease the entry of the peptide into the vascular network around the digestive tract. However, most slow-acting peptide therapeutics fail to achieve significant bioavailability through this procedure. The promising recent development of a phase-II GLP-1 analog that has a circulating half life of around one week by Novo Nordisk could open the doors for peptide therapeutics to be used on a wider scale in the treatment of several other diseases.

Which region presents the most lucrative opportunities for producers of peptide therapeutics?

Even though North America and Europe currently account for a majority share in the global peptide therapeutics market, the future of the market is expected to be dominated by Asia Pacific. The medical research sector in Asia Pacific has undergone significant development in the last few years, and the high prevalence of diabetes in Asian races means peptide therapeutics are not an entirely novel field.

Energy-efficient Models to Open New Avenues of Opportunity in Air Conditioning Systems

The considerable growth of the air conditioning system market can be attributed to the development of inverter air conditioners and smart thermostats. A large demand from the commercial and residential applications for efficient air conditioning systems has given a great push to the global market. The vendors are shifting their imperative focus towards energy efficiency and eco-friendly air conditioning system. The surge in concerns related to contamination of indoor air quality has spurred demand for advanced air-purifying technologies.

Increasing Demand from Commercial and Residential Sector to Drive the Sales of Air Conditioning Systems

Air conditioning systems find application in automotive, commercial, industrial, and residential sectors.  By revenue, the commercial segment is leading the global air conditioning systems market due to their increasing usage in areas such as clinics, construction, healthcare, hospitals, and hotel and tourism. The rising global temperature has increased the application of air conditioning systems in the residential sector, making it leading segment in terms of volume. The segment is also expected to register highest CAGR based on revenue from 2016 to 2024.

The market has been categorized into windows air conditioning systems, portable air conditioning systems, cassette ACs, chillers, splits, single packaged, and airside in terms of equipment type. While split ACs are dominating the global market at present, the portable air conditioning systems segment is anticipated to develop with the highest growth rate by 2024.


India, Japan, and China Likely to Boost the Market in APAC

In terms of geography, the global air conditioning system market is segmented into Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America. By revenue, Asia Pacific leads the market with the emergence of India, Japan, and China as strong contenders. Additionally, the growing trend for energy-efficient equipment is forecasted to provide a great push to the demand for air conditioning systems in the coming years.

The emergence of energy-efficient systems and the presence of several regulatory policies are escalating the growth of air conditioning systems market in North America and Europe. Latin America and MEA are also anticipated to register sustainable growth in the coming years, propelled by the ongoing technological evolution and changing standards of air conditioning and refrigerating systems in countries such as Saudi Arabia, Israel, Turkey, and the UAE.

Government Support Crucial for Widespread Adoption of Stem Cell Therapy

Stem cells are a type of human cells that give rise to the various types of cells found in the human body. Stem cells hold the potential to evolve into various types of human tissue, which has led to a growing acknowledgement of the obvious medical potential of this property. Stem cell therapy is becoming increasingly common in the treatment of various diseases and the increasing research in the field is expected to further drive the medical applications of stem cells in the coming years.

According to Transparency Market Research, government support is expected to be crucial in the global stem cells market’s expected rise from a 2013 valuation of US$26.3 bn to a valuation of US$119.5 bn by 2018. The market is expected to exhibit a robust 24.2% CAGR between 2012 and 2018.

Download Complete Healthcare Analytical Brochure: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

What are the major advances in the field of stem cells and their medical application?

In July 2016, a joint Dutch-Canadian research effort succeeded in discovering a viable method of increasing the amount of stem cells obtained from cord blood. Cord blood, which is blood from the placenta, contains a relatively small amount of stem cells per unit. The method formulated in the research allows researchers to increase the amount of stem cells obtained from cord blood, making this is a crucial advancement in the field of stem cell therapy. 

The team discovered that mirR-125a, a microRNA, is responsible for the property of stem cells to self-renew. This genetic ‘switch’ remains activated in stem cells but is inactivated in the progenitor cells formed from the division of stem cells. Success in activating this switch would result in self-sustaining production of stem cells, which will be a major boost for the global stem cell therapy market.

In April this year, a research team at McMaster University in Hamilton, Ontario, discovered the protein responsible for the growth and development of blood stem cells. The Musashi-2 protein could be the key to helping thousands of patients of various blood disorders, as understanding the ambit of the protein could allow researchers to increase the number of viable stem cells available for therapeutic use.

What are some of the major drivers for the stem cells market?

The key driver for the global stem cells market is the increasing government support across the world. As widespread incorporation of stem cell therapy allows a nation to significantly improve the overall healthcare scenario, countries in North America and Western Europe have provided solid support to stem cell research. The acceptance of stem cell therapy in emerging regions is still lagging behind due to the lack of advanced medical infrastructure to adopt stem cell therapy, but the steady improvement of the healthcare sector in countries such as India and China is likely to be a major growth driver for the global stem cells market.

The increasing prevalence of neurodegenerative disorders is another major driver for the global demand for stem cells. Neural tissue can’t be regenerated or replaced as easily as structural tissues, and the ability of stem cells to develop into human cells provides the perfect avenue for treatment of neurodegenerative conditions.

Emergence of Home-based Healthcare to Shape Utilization of Mobile Imaging Services

Mobile imaging services comprise a group of devices and technologies that allow diagnostic imaging to be conducted in non-hospital settings and the results sent to physicians. This is especially convenient in situations where the patient is suffering from disorders that restrain their movement, or the patient is in a remote area and can’t physically visit the hospital. The growing demand for home healthcare solutions is thus favorable for the mobile imaging services market. Hospitals themselves are also exhibiting increasing demand for mobile imaging services, as they present a cost-effective alternative over conventional fixed medical imaging equipment.

According to Transparency Market Research, the global mobile imaging services market was valued at US$10.7 bn in 2013. Exhibiting a steady 3.2% CAGR from 2014 to 2020, the market is expected to rise to a valuation of US$13.3 bn.

How important will hospitals be to the mobile imaging services market in the coming years?

Despite their obvious utility in healthcare dispensation to remote areas or in home-based healthcare settings, the primary driver for the demand for mobile imaging services is their increasing use in hospitals. While stationary imaging equipment has been the norm in hospitals for a long time, the impending obsolescence of many imaging devices in the face of consistent technological advancement has necessitated the use of cost-effective modern alternatives such as mobile imaging.

Small hospitals are the key end users of mobile imaging services. These hospitals need to keep in touch with the contemporaneous technological scenario, but the relatively low volume of patients doesn’t allow them to install advanced stationary equipment on a mass scale. In this situation, using outsourced mobile imaging services becomes a vital solution for hospitals operating in a certain budget range. This is the way the mobile imaging services market has shaped up in North America and Europe. The increasing sophistication of teleradiology technologies is likely to ensure it remains this way in the coming years.

Browse Research Release: 

What is the key trend in the global mobile imaging services market?

The launch of mobile imaging units by major hospitals is a key trend in the global mobile imaging services market. While it has increased the demand for mobile imaging equipment, the high transportation costs and frequent maintenance requirements may put many hospitals off the idea of establishing their own mobile imaging unit. The increasing ease of incorporating teleradiology solutions is also likely to count against the mobile imaging services market, especially with smaller hospitals.

The increasing global geriatric population has led to the development of imaging solutions that don’t require the patients to be physically present in the hospital, and home care solutions are already becoming common in North America and Western Europe, which are virtually the only markets for mobile imaging services at present. This is another key driver for the global mobile imaging services market.

Latest Post

Market Research Reports